NEC Display Solutions of America has received 510(K) market clearance from US Food and Drug Administration (FDA) for the MultiSync MD210C3 LCD, a cost-effective display with LED backlighting for diagnostic applications in healthcare organisations.
MD210C3 is a three-megapixel, 21.3in diagnostic monitor designed to meet the needs of healthcare facilities using a picture archiving and communication system (PACS) in diagnostic imaging.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Calibrated at the factory to the Digital Imaging and Communications in Medicine (DICOM) grayscale function for luminance, the diagnostic monitor features a front sensor to maintain calibrated brightness.
It also features a human sensor that reduces LCD brightness when the user leaves the monitor, which saves power and extends the life of the display.
All digital-connectors, including DisplayPort and a two-port USB hub, enable advanced connectivity for any type of workstation.
NEC Display Solutions Professional Desktop and Medical Displays product manager Art Marshall said: "The MD210C3 display is the latest in a line of NEC MultiSync Medical Series diagnostic displays to receive FDA 510(K) market clearance for radiology.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalData"Healthcare practitioners will enjoy its three megapixel colour imaging and high-quality panel in their work environments."
The company said the MultiSync MD210C3 display is available at a price of $4,299 and the package includes a five-year limited parts and labour warranty, including Advanced Overnight Exchange.
